News for Adaptive Biotechnologies Corporation Registered Shs

TipRanks 6d

Analysts Offer Insights on Healthcare Companies: Taysha Gene Therapies (TSHA), Soleno Therapeutics (SLNO) and Adaptive Biotechnologies (ADPT)

GlobeNewswire 19d

Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid...

TipRanks 19d

Adaptive Biotechnologies highlights new data at ASCO Meeting, EHA Congress

GlobeNewswire 21d

Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

TipRanks 34d

Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT) and Ovid Therapeutics (OVID)

TipRanks 43d

Adaptive Biotechnologies price target raised to $13 from $11 at Piper Sandler

TipRanks 43d

Piper Sandler Remains a Buy on Adaptive Biotechnologies (ADPT)

TipRanks 44d

Biotech Alert: Searches spiking for these stocks today

TipRanks 44d

Adaptive Biotechnologies price target raised to $9 from $7 at Morgan Stanley

TipRanks 44d

Scotiabank Keeps Their Buy Rating on Adaptive Biotechnologies (ADPT)

TipRanks 47d

Apple reports earnings beat, China weighs trade talks with U.S.: Morning Buzz

TipRanks 47d

J.P. Morgan Sticks to Its Buy Rating for Adaptive Biotechnologies (ADPT)

TipRanks 47d

BTIG Reaffirms Their Buy Rating on Adaptive Biotechnologies (ADPT)

TipRanks 47d

Analysts Are Bullish on Top Healthcare Stocks: Amgen (AMGN), Adaptive Biotechnologies (ADPT)

TipRanks 47d

Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT), CVS Health (CVS) and Cytokinetics (CYTK)

TipRanks 48d

Closing Bell Movers: Apple and Amazon slip after earnings

GlobeNewswire 48d

Adaptive Biotechnologies Reports First Quarter 2025 Financial Results

TipRanks 48d

Adaptive Biotechnologies reports Q1 EPS (20c), consensus (31c)

Seeking Alpha 48d

Adaptive Biotechnologies GAAP EPS of -$0.20 beats by $0.10, revenue of $52.44M beats by $10.31M

Seeking Alpha 48d

Here are the major earnings after the close today

Seeking Alpha 49d

Adaptive Biotechnologies Q1 2025 Earnings Preview

TipRanks 51d

Adaptive Biotechnologies (ADPT) Receives a Buy from BTIG

GlobeNewswire 69d

Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025

GlobeNewswire 71d

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma

TipRanks 71d

Adaptive Biotechnologies receives expanded medical coverage of clonoSEQ

TipRanks 79d

Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF), Adaptive Biotechnologies (ADPT) and Alnylam Pharma (ALNY)

TipRanks 85d

Biotech Alert: Searches spiking for these stocks today

Seeking Alpha 89d

Adaptive Biotech rises as Goldman Sachs upgrades on market dynamics

TipRanks 89d

Morning Movers: FedEx, Nike headline dip in corporate outlooks

TipRanks 89d

Adaptive Biotechnologies upgraded to Buy from Neutral at Goldman Sachs

TipRanks 89d

Adaptive Biotechnologies (ADPT) was upgraded to a Buy Rating at Goldman Sachs

TipRanks 92d

Adaptive Biotechnologies (ADPT) Gets a Buy from BTIG

GlobeNewswire 99d

Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma

TipRanks 99d

Adaptive Biotechnologies launches assay enhancements for clonoSeq

TipRanks 118d

Adaptive Biotechnologies price target raised to $11 from $7 at Piper Sandler

TipRanks 118d

Piper Sandler Sticks to Their Buy Rating for Adaptive Biotechnologies (ADPT)

TipRanks 125d

Adaptive Biotechnologies price target raised to $12 from $10 at Scotiabank

TipRanks 125d

Analysts Have Conflicting Sentiments on These Healthcare Companies: Adaptive Biotechnologies (ADPT), RegenXBio (RGNX) and Ramsay Health Care (OtherRMSYF)

TipRanks 126d

Piper Sandler Sticks to Their Buy Rating for Adaptive Biotechnologies (ADPT)

TipRanks 126d

Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT) and Springworks Therapeutics (SWTX)

GlobeNewswire 127d

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results

TipRanks 127d

Adaptive Biotechnologies sees FY25 operating expenses $340M-$350M

TipRanks 127d

Adaptive Biotechnologies reports Q4 EPS (23c), consensus (24c)

Seeking Alpha 127d

Adaptive Biotechnologies GAAP EPS of -$0.23 beats by $0.02, revenue of $47.46M beats by $1.41M

Seeking Alpha 127d

Here are the major earnings after the close today

Seeking Alpha 128d

Adaptive Biotechnologies Q4 2024 Earnings Preview

GlobeNewswire 133d

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

GlobeNewswire 147d

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025

GlobeNewswire 155d

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

Seeking Alpha 155d

Adaptive Biotechnologies and NeoGenomics partner to expand access to disease monitoring for blood cancer patients

	
		OSZAR »